Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management-Reference-Cited by-同舟云学术

Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management

Published:2019-12 Issue:6 Volume:33 Page:725-738
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Correale Michele,Tricarico Lucia,Grazioli Davide,Formica Ennio Sascia,Petrucci Rossella,Persichella Paola,Di Biase Matteo,Brunetti Natale Daniele^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-019-06920-x.pdf

Reference131 articles.

1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46:903–75.

2. Gurtner HP. Aminorex and pulmonary hypertension. A review Cor Vasa. 1985;27:160–71.

3. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137:376–87.

4. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry. Chest. 2012;142:448–56.

5. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53. pii: 1801913.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKα signaling;Clinical and Experimental Hypertension;2024-03-25

2. HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development;Comprehensive Physiology;2023-06-26

3. Target the concomitant risk factors for pulmonary hypertension in an HIV-positive man: a case report;2023-04-07

4. Cancer Therapy-Related Pulmonary Hypertension: A Review of Mechanisms and Implications for Clinical Practice;The Anatolian Journal of Cardiology;2023

5. Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis;British Journal of Clinical Pharmacology;2022-07-10